Evidence map›Paper›PMID 26744778›Full record

ArticleeLife2016

The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF.

Christina Kiel, Hannah Benisty, Veronica Lloréns-Rico, Luis Serrano

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. An interpretable molecular framework for predicting cancer driver missense mutations.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Colorectal cancer tumor phenotypes associated withWorld journal of gastrointestinal pathophysiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christina KielEMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation, Barcelona, Spain.
Hannah BenistyEMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation, Barcelona, Spain.
Veronica Lloréns-RicoEMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0860-5990
Luis SerranoEMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation, Barcelona, Spain.
Universitat Pompeu Fabra · ESInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many driver mutations in cancer are specific in that they occur at significantly higher rates than - presumably - functionally alternative mutations. For example, V600E in the BRAF hydrophobic activation segment (AS) pocket accounts for >95% of all kinase mutations. While many hypotheses tried to explain such significant mutation patterns, conclusive explanations are lacking. Here, we use experimental and in silico structure-energy statistical analyses, to elucidate why the V600E mutation, but no other mutation at this, or any other positions in BRAF's hydrophobic pocket, is predominant. We find that BRAF mutation frequencies depend on the equilibrium between the destabilization of the hydrophobic pocket, the overall folding energy, the activation of the kinase and the number of bases required to change the corresponding amino acid. Using a random forest classifier, we quantitatively dissected the parameters contributing to BRAF AS cancer frequencies. These findings can be applied to genome-wide association studies and prediction models.

Indexed as

Amino Acid SubstitutionEnzyme ActivationPoint MutationProtein FoldingCells, CulturedComputational BiologyHumansModels, MolecularMutant ProteinsMutation RateProtein ConformationProtein StabilityProto-Oncogene Proteins B-rafMutant ProteinsProto-Oncogene Proteins B-rafbiophysicscomputational biologygenotype-phenotype associationhumanpassenger and driver mutationsstructural biologystructure-energy calculationssystems biology

Identifiers

PMID26744778
PMCPMC4749552
OpenAlexW2227187202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.